Vanguard Portfolio Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.2M Sell
1,569,525
-81,768
-5% -$730K ﹤0.01% 2074
2026
Q2
$16.2M Buy
1,651,293
+205,314
+14% +$2.03M ﹤0.01% 2052
2026
Q1
$14.1M Buy
+1,445,979
New +$13.3M ﹤0.01% 2015

Other funds holding PRTA

Vanguard Portfolio Management's PRTA Position: Q3 2026 in Review

Vanguard Portfolio Management reduced its Prothena Corp (PRTA) stake by 5% in Q3 2026, selling an estimated $730K and leaving 1,569,525 shares worth $13.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2074.

Vanguard Portfolio Management first reported a position in PRTA in Q1 2026 and has held it in 3 quarters since. The position peaked at $16.2M in Q2 2026. 130 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.

  • Vanguard Portfolio Management held 1,569,525 shares of Prothena Corp worth $13.2M as of Q3 2026.
  • Vanguard Portfolio Management sold 81,768 Prothena Corp shares in Q3 2026, an estimated $730K.
  • Prothena Corp made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #2074 holding.
  • Vanguard Portfolio Management first reported a position in Prothena Corp in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Portfolio Management's Prothena Corp position peaked at $16.2M in Q2 2026.
  • 130 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.